The Department of Justice reached an $8.3 billion settlement with OxyContin-maker Purdue Pharma, but the administration’s proposed budget includes cuts that could reduce addiction coverage as substance use spikes during the pandemic.
The Department of Justice reached an $8.3 billion settlement with OxyContin-maker Purdue Pharma, but the administration’s proposed budget includes cuts that could reduce addiction coverage as substance use spikes during the pandemic.